Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 15400-58-5 | MDL No. : | MFCD11617311 |
Formula : | C8H10N2O4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | HDQHTPWKNFCTDN-UHFFFAOYSA-N |
M.W : | 198.18 | Pubchem ID : | 15050416 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.38 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 6.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 46.3 |
TPSA : | 70.54 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.04 cm/s |
Log Po/w (iLOGP) : | 2.22 |
Log Po/w (XLOGP3) : | 0.66 |
Log Po/w (WLOGP) : | 0.28 |
Log Po/w (MLOGP) : | -0.08 |
Log Po/w (SILICOS-IT) : | 0.73 |
Consensus Log Po/w : | 0.76 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.54 |
Solubility : | 5.75 mg/ml ; 0.029 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.72 |
Solubility : | 3.8 mg/ml ; 0.0192 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.99 |
Solubility : | 2.03 mg/ml ; 0.0103 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.19 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338-P310 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 52606-02-7 ]
2,4-Dimethoxypyrimidine-5-carbaldehyde
Similarity: 0.89
[ 72411-89-3 ]
4-Methoxypyrimidine-5-carboxylic acid
Similarity: 0.86
[ 944905-08-2 ]
2-(2,2,2-Trifluoroethoxy)pyrimidine-5-carboxylic acid
Similarity: 0.75
[ 90905-32-1 ]
2-Methoxypyrimidine-5-carbaldehyde
Similarity: 0.73
[ 4558-59-2 ]
4,6-Dimethoxypyrimidine-5-carbaldehyde
Similarity: 0.72
[ 4774-35-0 ]
Methyl 4-hydroxypyrimidine-5-carboxylate
Similarity: 0.86
[ 15400-53-0 ]
Ethyl 2-amino-4-hydroxypyrimidine-5-carboxylate
Similarity: 0.78
[ 20187-46-6 ]
Ethyl 4-amino-2-hydroxypyrimidine-5-carboxylate
Similarity: 0.75
[ 308348-93-8 ]
Methyl 2-aminopyrimidine-5-carboxylate
Similarity: 0.73
[ 65269-18-3 ]
Ethyl 4-chloro-2-methoxypyrimidine-5-carboxylate
Similarity: 0.71
[ 52606-02-7 ]
2,4-Dimethoxypyrimidine-5-carbaldehyde
Similarity: 0.89
[ 23945-44-0 ]
2,4-Dihydroxypyrimidine-5-carboxylic acid
Similarity: 0.89
[ 4774-35-0 ]
Methyl 4-hydroxypyrimidine-5-carboxylate
Similarity: 0.86
[ 72411-89-3 ]
4-Methoxypyrimidine-5-carboxylic acid
Similarity: 0.86
[ 38324-83-3 ]
2-Hydroxypyrimidine-5-carboxylic acid
Similarity: 0.80